Diabetes, Vol 35, Issue 12 1326-1331, Copyright © 1986 by American Diabetes Association

ARTICLES

Insulin dose-response characteristics for suppression of glycerol release and conversion to glucose in humans

N Nurjhan, PJ Campbell, FP Kennedy, JM Miles and JE Gerich

To compare the dose-response characteristics for suppression of lipolysis and suppression of glucose production by insulin, 13 normal nonobese individuals were infused with insulin at rates of 0.1, 0.2, 0.4, 0.8, and 1.6 mU X kg-1 X min-1 while normoglycemia was maintained with the glucose clamp technique. Glucose appearance and glycerol appearance (taken as index of lipolysis) were measured isotopically with simultaneous infusions of 3-[3H]glucose and U-[14C]glycerol. Baseline glucose and glycerol rates of appearance were 14 +/- 0.5 and 1.7 +/- 0.2 mumol X kg-1 X min-1, respectively. Approximately 3% of plasma glucose originated from glycerol, and this accounted for approximately 50% of glycerol disposal. During the insulin infusions, arterial insulin (basal, 9.8 +/- 0.6 microU/ml) increased to 14 +/- 0.5, 20 +/- 0.5, 31 +/- 1, 58 +/- 2, and 104 +/- 6 microU/ml; calculated portal venous insulin (basal, 24 +/- 2 microU/ml) increased to 26 +/- 1, 32 +/- 3, 70 +/- 4, and 115 +/- 6 microU/ml. The rate of glucose appearance was suppressed 100%, whereas the rate of appearance of glycerol was maximally suppressed only 85%. Nevertheless, the insulin concentration that produced half-maximal suppression of glucose appearance was twice as great as that required for half-maximal suppression of glycerol appearance (26 +/- 2 vs. 13 +/- 2 microU/ml, P less than .001). Insulin decreased both the absolute rate of glycerol conversion to plasma glucose and the percent of glycerol disposal appearing in plasma glucose (both P less than .001).(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				V. Qvisth, E. Hagstrom-Toft, S. Enoksson, E. Moberg, P. Arner, and J. Bolinder Human Skeletal Muscle Lipolysis Is More Responsive to Epinephrine Than to Norepinephrine Stimulation in Vivo J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 665 - 670. [Abstract] [Full Text] [PDF]

				V. Qvisth, E. Hagstrom-Toft, S. Enoksson, R. S. Sherwin, S. Sjoberg, and J. Bolinder Combined Hyperinsulinemia and Hyperglycemia, But Not Hyperinsulinemia Alone, Suppress Human Skeletal Muscle Lipolytic Activity in Vivo J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4693 - 4700. [Abstract] [Full Text] [PDF]

				L. C. C. Navegantes, M. Sjostrand, S. Gudbjornsdottir, L. Strindberg, M. Elam, and P. Lonnroth Regulation and Counterregulation of Lipolysis in Vivo: Different Roles of Sympathetic Activation and Insulin J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5515 - 5520. [Abstract] [Full Text] [PDF]

				O. Kunert, H. Stingl, E. Rosian, M. Krssak, E. Bernroider, W. Seebacher, K. Zangger, P. Staehr, V. Chandramouli, B.R. Landau, et al. Measurement of Fractional Whole-Body Gluconeogenesis in Humans From Blood Samples Using 2H Nuclear Magnetic Resonance Spectroscopy Diabetes, October 1, 2003; 52(10): 2475 - 2482. [Abstract] [Full Text] [PDF]

				E. Moberg, S. Sjoberg, E. Hagstrom-Toft, and J. Bolinder No apparent suppression by insulin of in vivo skeletal muscle lipolysis in nonobese women Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E295 - E301. [Abstract] [Full Text] [PDF]

				M. Sjostrand, S. Gudbjornsdottir, A. Holmang, L. Strindberg, K. Ekberg, and P. Lonnroth Measurements of Interstitial Muscle Glycerol in Normal and Insulin-Resistant Subjects J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2206 - 2211. [Abstract] [Full Text] [PDF]

				B. Mittendorfer, J. F. Horowitz, and S. Klein Gender differences in lipid and glucose kinetics during short-term fasting Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1333 - E1339. [Abstract] [Full Text] [PDF]

				M. D. Jensen, V. Chandramouli, W. C. Schumann, K. Ekberg, S. F. Previs, S. Gupta, and B. R. Landau Sources of blood glycerol during fasting Am J Physiol Endocrinol Metab, November 1, 2001; 281(5): E998 - E1004. [Abstract] [Full Text] [PDF]

				S. M. Sherck, M. Shiota, J. Saccomando, S. Cardin, E. J. Allen, J. R. Hastings, D. W. Neal, P. E. Williams, and A. D. Cherrington Pancreatic Response to Mild Non-Insulin-Induced Hypoglycemia Does Not Involve Extrinsic Neural Input Diabetes, November 1, 2001; 50(11): 2487 - 2496. [Abstract] [Full Text] [PDF]

				G. Perseghin, A. Caumo, M. Caloni, G. Testolin, and L. Luzi Incorporation of the Fasting Plasma FFA Concentration into QUICKI Improves Its Association with Insulin Sensitivity in Nonobese Individuals J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4776 - 4781. [Abstract] [Full Text] [PDF]

				N. Flattem, K. Igawa, M. Shiota, M. G. Emshwiller, D. W. Neal, and A. D. Cherrington {alpha}- and {beta}-Cell Responses to Small Changes in Plasma Glucose in the Conscious Dog Diabetes, February 1, 2001; 50(2): 367 - 375. [Abstract] [Full Text]

				S. Matthaei, M. Stumvoll, M. Kellerer, and H.-U. Häring Pathophysiology and Pharmacological Treatment of Insulin Resistance Endocr. Rev., December 1, 2000; 21(6): 585 - 618. [Abstract] [Full Text]

				M. Stumvoll, S. Jacob, H. G. Wahl, B. Hauer, K. Löblein, P. Grauer, R. Becker, M. Nielsen, W. Renn, and H. Häring Suppression of Systemic, Intramuscular, and Subcutaneous Adipose Tissue Lipolysis by Insulin in Humans J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3740 - 3745. [Abstract] [Full Text]

				R. E. Shangraw and F. Jahoor Lipolysis and lipid oxidation in cirrhosis and after liver transplantation Am J Physiol Gastrointest Liver Physiol, June 1, 2000; 278(6): G967 - G973. [Abstract] [Full Text] [PDF]

				S. Vehkavaara, S. Makimattila, A. Schlenzka, J. Vakkilainen, J. Westerbacka, and H. Yki-Jarvinen Insulin Therapy Improves Endothelial Function in Type 2 Diabetes Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 545 - 550. [Abstract] [Full Text] [PDF]

				M.-T. van der Merwe, P.-A. Jansson, N. J. Crowther, I. H. Boyd, I. P. Gray, B. I. Joffe, and P. N. Lönnroth Lactate and Glycerol Release from Subcutaneous Adipose Tissue in Black and White Lean Men J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2888 - 2895. [Abstract] [Full Text]

				R. L. Judd, R. Nelson, S. Klein, M. D. Jensen, and J. M. Miles Measurement of plasma glycerol specific activity by high performance liquid chromatography to determine glycerol flux J. Lipid Res., May 1, 1998; 39(5): 1106 - 1110. [Abstract] [Full Text]

				C. Robinson, W. V. Tamborlane, D. G. Maggs, S. Enoksson, R. S. Sherwin, D. Silver, G. I. Shulman, and S. Caprio Effect of insulin on glycerol production in obese adolescents Am J Physiol Endocrinol Metab, April 1, 1998; 274(4): E737 - E743. [Abstract] [Full Text] [PDF]

				I. Toft, K. H. Bonaa, O. C. Ingebretsen, A. Nordoy, K. I. Birkeland, and T. Jenssen Gender Differences in the Relationships Between Plasma Plasminogen Activator Inhibitor-1 Activity and Factors Linked to the Insulin Resistance Syndrome in Essential Hypertension Arterioscler. Thromb. Vasc. Biol., March 1, 1997; 17(3): 553 - 559. [Abstract] [Full Text]